Purchase Order 75D30121P11493
Award Date 6/15/21
Potential Completion Date 9/30/21
Potential Value $126K
Federal Agency
Ultimate Awardee
Not listed NAICS Category
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Alameda, CA 94502, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
1
Legislative Mandate
Other Statutory Authority
National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Department of Health and Human Services Centers for Disease Control and Prevention awarded a $148,545.00 firm-fixed-price purchase order contract to Fluxion Biosciences Inc., a manufacturer of automated patch clamp, cellular analysis, and liquid biopsy systems. The contract is for the delivery of laboratory equipment and has a completion date of September 30, 2020. This contract does not have a set-aside designation. Fluxion Biosciences has previously provided specialized bio fluxion...
- The Department of Health and Human Services Centers for Disease Control and Prevention awarded a $110,000 firm fixed price purchase order to Fluxion Biosciences Inc. (doing business as Fluxion) to upgrade the Ionflux Mercury 16 to a 96- to 386-well capability. This sole source contract was awarded without a set-aside, and is for supplies or services for which the government intends to contract with only one source under the authority of FAR 13.106-1(b)(1) and 10 U.S.C. 2304(c)(1). The upgrade is...
- The Department of Health and Human Services Centers for Disease Control and Prevention awarded a firm-fixed price purchase order contract to Standard Biotools Inc., doing business as Fluidigm, for $16,805.00. Fluidigm is a company that provides products and services to support scientific research in areas such as cancer, inflammatory diseases, immunotherapies, and environmental monitoring. This contract does not have a set-aside designation. Fluidigm has received over 50 prime federal contract...
- The Department of Health and Human Services Centers for Disease Control and Prevention awarded a firm-fixed price purchase order to Standard Biotools Inc., doing business as Fluidigm, for the provision of lab equipment, supplies, and reagents for the Juno System, with an interface plate. The total potential value of this award is $128,422.40, and the period of performance ends on October 31, 2021. Fluidigm is a for-profit manufacturer that has received over 50 prime federal contract awards...
- The Department of Health and Human Services Centers for Disease Control and Prevention awarded a firm-fixed price purchase order contract to Standard Biotools Inc., doing business as Fluidigm, for the provision of a laboratory instrument. The $122,580.34 contract has a performance period ending on May 30, 2023 and does not include any set-aside designation. Fluidigm is a for-profit manufacturer that has received over 50 prime federal contract awards from agencies such as the National...
- This is a $83,832 firm fixed-price purchase order contract awarded by the Centers for Disease Control and Prevention (CDC) to Standard Biotools Inc., doing business as Fluidigm, on February 26, 2019. The contract is for the delivery of laboratory reagents, with a completion date of February 27, 2019. Fluidigm is a for-profit organization and manufacturer of advanced scientific instruments, reagents, and related products and services. The contract does not have a small business set-aside...
- The federal contract award to Fluidigm Corporation (doing business as Standard Biotools Inc.) is a $206,895.10 firm-fixed-price purchase order from the Centers for Disease Control and Prevention (CDC) Pittsburgh. The contract, which does not have a set-aside designation, is for the provision of scientific instruments, reagents, and associated maintenance services to support the CDC's research efforts. Fluidigm is an experienced federal contractor, with over 50 prime contract awards from...
- The Department of Health and Human Services (HHS) Centers for Disease Control and Prevention (CDC) awarded a $158,106.80 firm-fixed-price purchase order to Standard Biotools Inc., doing business as Fluidigm, on June 30, 2021. The award does not have a set-aside designation. Fluidigm is a for-profit manufacturer that provides products and services to support federal research efforts, with major customers including the National Institutes of Health, CDC, Department of Veterans Affairs, and...
- This delivery order for $34,150 was awarded by the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 17 to Fluxion Biosciences Inc., doing business as Fluxion, on February 1, 2023. The order is for the procurement of bio fluxion equipment with performance due by January 31, 2028. The contract type is firm fixed price and no set-aside designation was used. The place of performance is Houston, Texas. This order was issued under an existing contract...
- This is a definitive contract awarded by the Centers for Disease Control and Prevention (CDC) to Fluoresentric, Inc., a manufacturer of goods registered to receive federal government awards. The contract, valued at $207,900.00, is for the provision of CBOT singleplex assays, which are laboratory reagents and diagnostic testing materials that support the CDC's mission of disease control and prevention. The contract has a firm fixed price pricing type and a performance period ending on August 7,...
The Department of Health and Human Services Centers for Disease Control and Prevention awarded a firm fixed-price purchase order contract worth $126,311.80 to Fluxion Biosciences Inc., a manufacturer of automated patch clamp, cellular analysis, and liquid biopsy systems. The contract is for a "Recombinant Cell Line" with a completion date of September 30, 2021. Fluxion Biosciences Inc. has previously provided specialized biofluxion equipment, upgrades, cell lines, and microfluidic devices to agencies including the VA, CDC, and NIH through federal contracts and grants. This award does not have a set-aside designation.
Generated 3/24/24, 2:04 AM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $126.3k | 6/15/21 |